Hela Apparel Holdings PLC has announced a significant improvement in its financial performance during the quarter ended 30th September, with a return to operating profit for the first time in eight ...
Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announces that AstraZeneca has ...